Drug Use Clinical Trial
— GAME-OVEROfficial title:
Drug Wastage : Observational Study in Intensive Care Units in France
Verified date | March 2024 |
Source | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Environmental awareness leads medical field to question its responsibility and possibilities for action. Drug residues can have a major environmental impact as per their bioaccumulation, toxicity and persistence characteristics, depending on where they are discarded. In France, drug residues should be disposed of by incineration, but in practice, this is not systematic. Moreover, data on drug wastage in Intensive Care Units (ICU) are rare. GAME-OVER observational study aims to evaluate drug wastage in ICU in France and to suggest ways to improve health care practices.
Status | Completed |
Enrollment | 1066 |
Est. completion date | March 15, 2023 |
Est. primary completion date | March 15, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult patients hospitalized in intensive care units during the 24 hours of data collection. Exclusion Criteria: - Patient's opposition to participate in the study or patient family opposition if the patient is not able to be informed. |
Country | Name | City | State |
---|---|---|---|
France | CHU d'Amiens | Amiens | Somme |
France | CHU d'Angers | Angers | Maine-et-Loire |
France | Hôpital privé d'Antony | Antony | Hauts-de-Seine |
France | Centre Hospitalier Victor Dupouy | Argenteuil | Val d'Oise |
France | Centre Hospitalier d'Aurillac | Aurillac | Cantal |
France | CHU de Besançon | Besançon | Doubs |
France | Centre Hospitalier Simone Veil | Blois | Loir-et-Cher |
France | CHU de Bordeaux - Hôpital Pellegrin | Bordeaux | Gironde |
France | Clinique Saint Augustin | Bordeaux | Gironde |
France | HIA Robert Picqué | Bordeaux | Gironde |
France | CHRU de Brest | Brest | Finistère |
France | HIA Clermont Tonnerre | Brest | Finistère |
France | Hôpital Pierre Wertheimer | Bron | Rhône |
France | Centre Hospitalier de Cahors | Cahors | Lot |
France | CHRU de Tours | Chambray-lès-Tours | Indre-et-Loire |
France | Centre Hospitalier de Charleville-Mezieres | Charleville-Mézières | Ardennes |
France | HIA Percy-Clamart | Clamart | Hauts-de-Seine |
France | CHU de Clermont-Ferrand | Clermont-Ferrand | Puy-de-Dôme |
France | Hôpital Henri Mondor | Créteil | Val-de-Marne |
France | Centre Hospitalier de Dax | Dax | Landes |
France | Groupe Hospitalier Littoral Atlantique | La Rochelle | Charente-Maritime |
France | CHU de Grenoble | La Tronche | Isère |
France | Centre Hospitalier de Versailles | Le Chesnay | Yvelines |
France | Centre Hospitalier Emile Roux | Le Puy-en-Velay | Haute-Loire |
France | Hôpital Robert Boulin | Libourne | Gironde |
France | CHU de Lille - Hôpital Huriez | Lille | Nord |
France | CHU de Lille - Hôpital Roger Salengro | Lille | Nord |
France | CHU Dupuytren | Limoges | |
France | Clinique de la Sauvegarde | Lyon | Rhône |
France | Hôpital Edouard Herriot | Lyon | Rhône |
France | Hôpital Nord | Marseille | Bouches Du Rhône |
France | Grand Hôpital de l'Est Francilien | Meaux | Seine-et-Marne |
France | Centre Hospitalier de Mont-de-Marsan | Mont-de-Marsan | Landes |
France | Centre Hospitalier du Forez | Montbrison | Loire |
France | Centre Hospitalier de Montélimar | Montélimar | Drôme |
France | Hôpital Américain de Paris | Neuilly-sur-Seine | Hauts-de-Seine |
France | CHU de Nîmes | Nîmes | Gard |
France | Centre Hospitalier d'Orléans | Orléans | Loiret |
France | Hôpital Bichat | Paris | |
France | Hôpital La Pitié-Salpétrière | Paris | |
France | Hôpital Lariboisière | Paris | |
France | CHU de Poitiers | Poitiers | Vienne |
France | Hôpital privé Claude Galien | Quincy-sous-Sénart | Essonne |
France | Clinique la Croix du Sud | Quint-Fonsegrives | Haute-Garonne |
France | CHU de Reims | Reims | Marne |
France | CHU de Rennes | Rennes | Ille-et-Vilaine |
France | CHU Félix-Guyon | Saint-Denis | Réunion |
France | Centre Hospitalier Mémorial de Saint-Lô | Saint-Lô | Manche |
France | Centre Hospitalier de Saint Nazaire | Saint-Nazaire | Loire-Atlantique |
France | CHU de la Réunion | Saint-Pierre | Réunion |
France | CHU de Saint-Etienne | Saint-Priest-en-Jarez | Loire |
France | CHRU de Strasbourg | Strasbourg | Bas-Rhin |
France | HIA Sainte Anne | Toulon | Var |
France | Hôpital Sainte Musse | Toulon | Var |
France | CHU de Toulouse - Hôpital Purpan | Toulouse | Haute Garonne |
France | CHU de Toulouse - Hôpital Rangueil | Toulouse | Haute-Garonne |
France | Clinique Pasteur | Toulouse | Haute-Garonne |
France | Hôpital Nord Franche-Comté | Trévenans | Territoire De Belfort |
France | Centre Hospitalier Bretagne Atlantique de Vannes | Vannes | Morbihan |
Mayotte | Centre Hospitalier de Mayotte | Mamoudzou | |
Monaco | Centre Hospitalier Princesse Grace | Monaco |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | Sainte-Anne Military Teaching Hospital |
France, Mayotte, Monaco,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ratio of overall wastage in milliliter (mL) of prepared and discarded IV drugs to overall volume in milliliter (mL) of prepared IV drugs. | Wastage is defined as any prepared and unused drug that remains in syringe or IV bag. | 24 hours | |
Secondary | Reason for discarding drug residues | A questionnaire will be fulfilled by healthcare teams with the following possible categories:
1/ prepared in advance and not used ; 2/ systematic change at fixed times ; 3/ prescription change ; 4/ change by anticipation of care ; 5/ drug no longer needed ; 6/ preparation error ; 7/ other reason. |
24 hours | |
Secondary | Drug residues discarding process | A questionnaire will be used to determine which discarding process are applied by nurses in their usual pratices. | 24 hours | |
Secondary | Use of enteral administration route | Use of enteral administration route versus per os and IV routes will be analyzed for paracetamol and proton pump inhibitor according to the accessibility of enteral route and the reason and the date of patient entry in ICU. | 24 hours | |
Secondary | Cost of overall IV drug wastage | Estimated cost of drug residues will be evaluated for each drug, according to the reason for discarding, by the following formula :
volume of discarded IV drugs x theoretical price |
24 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05468879 -
Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects
|
N/A | |
Not yet recruiting |
NCT06395129 -
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
|
||
Completed |
NCT02293057 -
Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
|
N/A | |
Completed |
NCT01941108 -
Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care
|
N/A | |
Completed |
NCT01380613 -
Neighborhoods, Networks, Depression, and HIV Risk
|
Phase 2 | |
Withdrawn |
NCT00914719 -
Alcohol Use and Sexual Risk: An Intervention
|
N/A | |
Recruiting |
NCT03671629 -
Pharmacist Intervention to Reduce Drug-related Readmissions Among the Elderly
|
N/A | |
Completed |
NCT03290391 -
Linking Infectious and Narcology Care-Part II
|
Phase 4 | |
Completed |
NCT04008927 -
A Community-based Intervention Among Active Drug Users in Montpellier
|
N/A | |
Completed |
NCT03627546 -
HCV Seek, Test and Rapid Treatment for Young PWID
|
N/A | |
Not yet recruiting |
NCT03967262 -
Secondary Prevention and Recidivism Reduction in Trauma Patients
|
N/A | |
Completed |
NCT03079856 -
Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER
|
N/A | |
Completed |
NCT03855410 -
Preventing Cigarette Use Among Urban Youth Via an M-Health Primary Care Preventive Intervention
|
N/A | |
Terminated |
NCT02457949 -
The Impact of Alternative Social Assistance Disbursement on Drug-related Harm
|
N/A | |
Completed |
NCT06238154 -
Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds
|
Phase 4 | |
Terminated |
NCT04436055 -
Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)
|
||
Recruiting |
NCT04717856 -
Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA
|
N/A | |
Completed |
NCT00249496 -
Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1
|
N/A | |
Recruiting |
NCT05597865 -
Assessing the Feasibility of Economic Approaches to Prevent Substance Abuse Among Adolescents
|
N/A | |
Completed |
NCT03718520 -
The Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural Connectivity
|